Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
---|
02/20/2014 | WO2014028946A2 Modulators of hepatic lipoprotein metabolism |
02/20/2014 | WO2014027053A1 Benzimidazoles for the treatment of cancer |
02/19/2014 | EP2698367A1 Benzimidazoles for the treatment of cancer |
02/19/2014 | EP2697231A1 Continuously operable method for producing carbonyl compounds by means of a catalyst containing a nitroxyl radical |
02/19/2014 | EP2697222A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent |
02/19/2014 | CN203436848U Crystal crystallizing tank for artemisinin |
02/19/2014 | CN103589423A Fluorescent probe containing N, N-diethyl p-thylaminophenol and application thereof in thiophenol detection |
02/19/2014 | CN103588785A Refining method for ginkgolide A and ginkgolide B |
02/19/2014 | CN103588784A Method for preparing high-purity nemadectin |
02/19/2014 | CN103588783A Epigambogic alcohol acid, as well as preparation method and medical application thereof |
02/19/2014 | CN103588782A Gambogellic acid as well as preparation method and application thereof to medicines |
02/19/2014 | CN103588781A Preparation method of 1,6-dioxaspiro [4, 4] nonane-3,8-diene derivative |
02/19/2014 | CN103588780A Barium cantharidate and preparation method thereof |
02/19/2014 | CN103588779A Manganese cantharidate and preparation method thereof |
02/19/2014 | CN103588778A Strontium cantharidate and preparation method thereof |
02/19/2014 | CN103588777A Method for synthesizing 2-benzoyl-2H-furo[3, 2-c]coumarin derivatives |
02/19/2014 | CN102796113B Xanthone compound, and preparation method and application thereof |
02/18/2014 | US8652527 Extended-release topiramate capsules |
02/13/2014 | WO2014024898A1 Method for producing hexahydrofurofuranol derivative |
02/13/2014 | WO2014024769A1 Method for synthesizing anti-anthradichalcogenophene |
02/13/2014 | WO2014023902A1 Method for preparing dialkyloxydianhyrohexitol by etherification of dianhydrohexitol using a light alcohol, in the presence of an acidic catalyst |
02/13/2014 | WO2014023789A1 Method of synthesis of a composition containing at least one internal dehydration product of a hydrogenated sugar by heterogeneous catalysis |
02/13/2014 | WO2014023081A1 Artemisinin derivatives, preparation process and use thereof |
02/12/2014 | EP2694482A1 Wnt pathway antagonists |
02/12/2014 | CN203425580U Filter for artemisinin refinement |
02/12/2014 | CN203425539U Alcohol evaporation tank for artemisinin refinement |
02/12/2014 | CN103570742A Condensation compound and organic light emitting device including same |
02/12/2014 | CN103570740A Preparation process of artemether |
02/12/2014 | CN103570739A Method for separating arteannuic acid from artemisia annua essential oil |
02/12/2014 | CN103570738A Novel artemisinin derivatives and preparation method and use thereof |
02/12/2014 | CN103570737A Heterocyclic compounds, organic light-emitting device comprising the same and organic light-emitting display |
02/12/2014 | CN103570735A Novel heterocyclic compounds and organic light emitting device comprising the same |
02/12/2014 | CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines |
02/12/2014 | CN103570657A Phenyl-glucoside derivative containing gem-dimethyl, preparation method and use thereof |
02/12/2014 | CN103570653A Heterocyclic compound, organic light-emitting device including the same , and organic light-emitting display device |
02/12/2014 | CN103566008A Saururus chinensis extract as well as preparation method and application thereof |
02/06/2014 | WO2014020105A1 Griseofulvin derivatives |
02/06/2014 | WO2014020101A1 Griseofulvin derivatives |
02/06/2014 | WO2014019685A1 Novel chartreusin analogues |
02/06/2014 | US20140039202 Method for separating and purifying ginkgolide c from root bark of ginkgo |
02/06/2014 | US20140039045 Composition of monoterpenoids having bactericidal properties |
02/06/2014 | US20140039010 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor |
02/06/2014 | DE102013206380A1 Verbindung und diese umfassende organische lichtemittierende Vorrichtung Connection and this comprehensive organic light emitting device |
02/05/2014 | EP2693464A1 Method for producing organic transistor, organic transistor, method for producing semiconductor device, semiconductor device, and electronic apparatus |
02/05/2014 | CN103554128A Avermectin benzoate compounds and synthetic method thereof |
02/05/2014 | CN103554127A Preparation method of beta-artemether |
02/05/2014 | CN103554126A Preparation method and application of fluorescein derivative serving as tracer agent for oil field |
02/05/2014 | CN103554125A 4alpha-acyloxy-2'(2',6'),2alpha-polyhalogenated podophyllotoxin derivatives as well as preparation method and application thereof |
02/05/2014 | CN103554124A Bioactive components in bamboo leaf green liquor and medical application thereof |
02/05/2014 | CN103554087A Dabigatran derivative, as well as preparation method and antithrombus application thereof |
02/04/2014 | US8642789 Co-crystal compound, method for preparing the same and oxidant of gas generator propellant |
02/04/2014 | CA2573969C Oxidative degradation products of atorvastatin calcium |
02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
01/30/2014 | WO2014018671A1 Therapeutic compounds for the treatment of cancer |
01/30/2014 | WO2014016241A1 Process for homogeneously catalysed amination of alcohols with ammonia in the presence of a complex catalyst without anionic ligands |
01/30/2014 | US20140031406 Pyrazole compound |
01/30/2014 | US20140031388 Akt inactivation by tocopheryl derivatives |
01/30/2014 | DE102013214399A1 Heterocyclische Verbindungen und organische lichtemittierende Vorrichtungen, die diese aufweisen Heterocyclic compounds and organic light emitting devices having these |
01/30/2014 | DE102013202562A1 New heterocyclic compounds, useful in an organic LED of a flat panel display device, and as a fluorescent dopant and a phosphorescent host |
01/29/2014 | EP2690103A1 Ortho ester derivative, liquid crystal composition, and liquid crystal display element |
01/29/2014 | EP2689780A1 Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group |
01/29/2014 | CN103539801A Podophyllotoxin derivative as well as salt, preparation method and application thereof |
01/29/2014 | CN103539769A Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
01/29/2014 | CN102757440B 1-(6,7-dihydro-5H-furan-[3,2-g]chromene-3-acetyl)-4-phenylpiperazine and applications thereof |
01/29/2014 | CN101228154B Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
01/28/2014 | CA2686468C Polyhydroxylated aromatic compounds for the treatment of amyloidosis |
01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
01/28/2014 | CA2459168C Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol |
01/23/2014 | WO2014013272A1 Rhodamine based fluorescent probe for coagulase activity and detection of coagulase producing bacterial strains |
01/23/2014 | WO2014012858A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
01/23/2014 | WO2014012371A1 Compounds of chiral aromatic spiroketal diphosphine ligands, preparation methods and uses thereof |
01/23/2014 | US20140024833 Process for the homogeneously catalyzed amination of alcohols with ammonia in the presence of a complex catalyst which comprises no anionic ligands |
01/23/2014 | US20140024681 Compounds with super-aspirin effects |
01/23/2014 | US20140023699 Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration |
01/22/2014 | EP2687511A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
01/22/2014 | EP2685828A1 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
01/22/2014 | CN103534254A Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent |
01/22/2014 | CN103524527A Method for simultaneously extracting arteannuic acid and dihydroarteannuic acid from liquid waste after separation of artemisinin |
01/22/2014 | CN103524526A Separation and purification method of bilobalide |
01/22/2014 | CN103524525A Method for extracting arteannuic acid and arteannuic acid derivative from artemisinin production waste |
01/22/2014 | CN103524524A New compound in fructus schizandrae as well as preparation and application method of new compound |
01/22/2014 | CN103524523A Trichodermin C8 oxime ether derivatives and application thereof |
01/22/2014 | CN103524522A Method for separation and purification of 2,3-dihydroxy-1,8-cineole in reaction mixture |
01/22/2014 | CN103524521A Preparation method of blackberry ellagic acid |
01/22/2014 | CN103524520A Method for extracting parthenolide from plant raw material |
01/22/2014 | CN103524461A A method for manufacturing an epoxy compound and an epoxy compound |
01/21/2014 | US8633326 Method for preparing taxane derivatives |
01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
01/21/2014 | CA2597777C Spiroketal-substituted cyclic ketoenols |
01/16/2014 | WO2014009020A1 Photochromic fluorenopyrans with defined dibenzo[b,d]pyrano fused attachment |
01/16/2014 | US20140018342 Gamma secretase inhibitors |
01/15/2014 | EP2684885A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
01/15/2014 | EP2684884A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
01/15/2014 | EP2684883A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
01/15/2014 | EP2684882A1 Novel compounds obtained from gamboge resin, and medical uses of the same |
01/15/2014 | CN103517908A Sesterterpene compounds and use thereof |
01/15/2014 | CN103509034A Method for extracting artemisinin from fresh artemisia annua |
01/15/2014 | CN103509033A Beta-artemether polymorphic substances and preparation methods thereof |
01/15/2014 | CN103509032A Batch green synthesis method of dioxaanthanthrene oxygenated fused ring compound |
01/15/2014 | CN103509031A Preparation method of Darunavir amorphous matter |